TipRanks
Go Ultimate55% OFF

Compare Akari Therapeutics (CLA1) vs. Competitors

Comparison Results

Comparison results
NamePriceMarket CapP/E RatioYearly GainAnalyst ConsensusAnalyst Price TargetCompareTop Analysts' Price TargetSmart ScoreFollow
DE:CLA1Akari TherapeuticsEUR 0.06EUR 12.91M-0.01-99.74%Strong BuyUnlock the DE:CLA1 analyst price target with TipRanks PremiumDE:CLA1Unlock the DE:CLA1 top-analyst price target with TipRanks Premium
NNVCNanoViricides$1.37$33.95M-3.23-21.76%Moderate BuyUnlock the NNVC analyst price target with TipRanks PremiumDE:CLA1 vs NNVCUnlock the NNVC top-analyst price target with TipRanks Premium
MBRXMoleculin Biotech$8.16$8.29M-0.02-96.50%Strong BuyUnlock the MBRX analyst price target with TipRanks PremiumDE:CLA1 vs MBRXUnlock the MBRX top-analyst price target with TipRanks Premium
PASGPassage Bio$3.45$11.10M-0.30-53.38%NeutralUnlock the PASG analyst price target with TipRanks PremiumDE:CLA1 vs PASGUnlock the PASG top-analyst price target with TipRanks Premium
SABSSAB Biotherapeutics$3.31$304.80M0.9411.30%Strong BuyUnlock the SABS analyst price target with TipRanks PremiumDE:CLA1 vs SABSUnlock the SABS top-analyst price target with TipRanks Premium

Performance Comparison

-100%-50%0%50%100%150%200%Dec '25Jan '26Feb '26Mar '26Apr '26May '26Jun '26Jul '26Aug '26Sep '26Oct '26
Performance comparison by fund
TickerCompany NamePriceChange% Change
DE:CLA1Akari Therapeutics0.06-22.74-99.73%
NNVCNanoViricides1.33-0.70-34.48%
MBRXMoleculin Biotech7.90-251.95-96.96%
PASGPassage Bio3.45-3.87-52.87%
SABSSAB Biotherapeutics3.350.103.08%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts